Second-generation antipsychotic use during pregnancy and risk of congenital malformationsMaria Ellfolk, Heli Malm, Maarit K. Leinonen et al.|European Journal of Clinical Pharmacology|2021Cited by 34
Linking a European cohort of children born with congenital anomalies to vital statistics and mortality records: A EUROlinkCAT studyMaria Loane, Joan K. Morris, Sonja Kiuru‐Kuhlefelt et al.|PLoS ONE|2021Cited by 32
Survival of children with rare structural congenital anomalies: a multi-registry cohort studyAlessio Coi, Joan K. Morris, Michele Santoro et al.|Orphanet Journal of Rare Diseases|2022Cited by 19
Temporal and geographical variations in survival of children born with congenital anomalies in Europe: A multi‐registry cohort studyMichele Santoro, Joan K. Morris, Alessio Coi et al.|Paediatric and Perinatal Epidemiology|2022Cited by 18
Prescription of cardiovascular medication in children with congenital heart defects across six European Regions from 2000 to 2014: data from the EUROlinkCAT population-based cohort studyMads Damkjær, Joan K. Morris, Stine Kjær Urhøj et al.|BMJ Open|2022Cited by 8